Kristina Striepe

1.6k total citations
33 papers, 539 citations indexed

About

Kristina Striepe is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Kristina Striepe has authored 33 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 14 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Nephrology. Recurrent topics in Kristina Striepe's work include Diabetes Treatment and Management (13 papers), Blood Pressure and Hypertension Studies (10 papers) and Cardiovascular Health and Disease Prevention (9 papers). Kristina Striepe is often cited by papers focused on Diabetes Treatment and Management (13 papers), Blood Pressure and Hypertension Studies (10 papers) and Cardiovascular Health and Disease Prevention (9 papers). Kristina Striepe collaborates with scholars based in Germany, Poland and Belarus. Kristina Striepe's co-authors include Roland E. Schmieder, Christian Ott, Marina V. Karg, Dennis Kannenkeril, Agnes Bosch, Susanne Jung, Peter Bramlage, Agnes Jumar, Stefanie Friedrich and Markus P. Schneider and has published in prestigious journals such as PLoS ONE, Scientific Reports and European Heart Journal.

In The Last Decade

Kristina Striepe

28 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina Striepe Germany 10 362 195 154 129 81 33 539
Agnes Bosch Germany 13 295 0.8× 218 1.1× 150 1.0× 124 1.0× 106 1.3× 45 568
Marina V. Karg Germany 7 309 0.9× 145 0.7× 129 0.8× 111 0.9× 68 0.8× 17 422
Susanne Jung Germany 11 183 0.5× 175 0.9× 82 0.5× 68 0.5× 59 0.7× 30 364
Giuseppe Andronico Italy 17 295 0.8× 631 3.2× 124 0.8× 75 0.6× 96 1.2× 35 896
Anna L. Emanuel Netherlands 8 229 0.6× 68 0.3× 155 1.0× 65 0.5× 65 0.8× 9 391
Tetsutaro Matayoshi Japan 12 104 0.3× 192 1.0× 49 0.3× 83 0.6× 68 0.8× 25 403
Graham S. Scott United Kingdom 4 275 0.8× 170 0.9× 59 0.4× 93 0.7× 86 1.1× 6 559
Philip A. Coates United Kingdom 11 324 0.9× 93 0.5× 173 1.1× 92 0.7× 39 0.5× 16 540
Eita Kumagai Japan 12 124 0.3× 133 0.7× 64 0.4× 70 0.5× 37 0.5× 28 393
L Hanna United States 8 222 0.6× 187 1.0× 77 0.5× 73 0.6× 30 0.4× 11 616

Countries citing papers authored by Kristina Striepe

Since Specialization
Citations

This map shows the geographic impact of Kristina Striepe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Striepe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Striepe more than expected).

Fields of papers citing papers by Kristina Striepe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Striepe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Striepe. The network helps show where Kristina Striepe may publish in the future.

Co-authorship network of co-authors of Kristina Striepe

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Striepe. A scholar is included among the top collaborators of Kristina Striepe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Striepe. Kristina Striepe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kannenkeril, Dennis, Julie Kolwelter, Peter Linz, et al.. (2025). Short- and Mid-Term Effects of Empagliflozin on Sodium Balance and Fluid Regulation in Chronic Heart Failure. European Journal of Heart Failure. 27(12). 3134–3141.
3.
Kannenkeril, Dennis, Agnes Bosch, Julie Kolwelter, et al.. (2024). PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease. Clinical Research in Cardiology. 115(2). 220–231. 1 indexed citations
4.
Bosch, Agnes, Kristina Striepe, Peter Bramlage, et al.. (2024). Is GFR decline induced by SGLT2 inhibitor of clinical importance?. Cardiovascular Diabetology. 23(1). 184–184. 5 indexed citations
5.
Bosch, Agnes, Dennis Kannenkeril, Christian Ott, et al.. (2023). Relation between waist circumference and the renal hemodynamic in healthy individuals. Nutrition Metabolism and Cardiovascular Diseases. 34(3). 755–762. 2 indexed citations
6.
Bosch, Agnes, Marko Poglitsch, Dennis Kannenkeril, et al.. (2023). Angiotensin Pathways Under Therapy with Empagliflozin in Patients with Chronic Heart Failure. ESC Heart Failure. 10(3). 1635–1642. 5 indexed citations
7.
8.
Bosch, Agnes, Dennis Kannenkeril, Kristina Striepe, et al.. (2022). Is Vascular Remodelling in Patients with Chronic Heart Failure Exaggerated?. ESC Heart Failure. 10(1). 245–254. 3 indexed citations
9.
Kannenkeril, Dennis, Agnes Bosch, Julie Kolwelter, et al.. (2021). Dependency of flow‐mediated vasodilatation from basal nitric oxide activity. Clinical Physiology and Functional Imaging. 41(4). 310–316. 8 indexed citations
10.
Kannenkeril, Dennis, Rolf Janka, Agnes Bosch, et al.. (2021). Detection of Changes in Renal Blood Flow Using Arterial Spin Labeling MRI. American Journal of Nephrology. 52(1). 69–75. 6 indexed citations
11.
Kolwelter, Julie, Agnes Bosch, Kristina Striepe, et al.. (2021). Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure. Cardiovascular Diabetology. 20(1). 219–219. 40 indexed citations
12.
Kannenkeril, Dennis, Susanne Jung, Joanna Haraźny, et al.. (2021). Tissue sodium content correlates with hypertrophic vascular remodeling in type 2 diabetes. Journal of Diabetes and its Complications. 35(12). 108055–108055. 4 indexed citations
13.
Ott, Christian, Susanne Jung, Dennis Kannenkeril, et al.. (2021). Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine. Cardiovascular Diabetology. 20(1). 178–178. 21 indexed citations
14.
Ott, Christian, Susanne Jung, Agnes Bosch, et al.. (2019). 4.6 Effects of Combined Therapy of Empagliflozin and Linagliptin Versus Metformin and Insulin Glargine on Blood Pressure and Vascular Function in Patients with Type 2 Diabetes. Artery Research. 25(S1). S35–S35. 1 indexed citations
15.
Bosch, Agnes, Christian Ott, Susanne Jung, et al.. (2019). How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial. Cardiovascular Diabetology. 18(1). 44–44. 85 indexed citations
16.
Jung, Susanne, Agnes Bosch, Dennis Kannenkeril, et al.. (2019). Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes. European Heart Journal - Cardiovascular Pharmacotherapy. 6(6). 364–371. 12 indexed citations
17.
Karg, Marina V., Agnes Bosch, Dennis Kannenkeril, et al.. (2018). SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial. Cardiovascular Diabetology. 17(1). 5–5. 146 indexed citations
18.
Ott, Christian, Agnes Jumar, Kristina Striepe, et al.. (2017). A Randomized Study of the Impact of the SGLT2 Inhibitor Dapagliflozin on Microvascular and Macrovascular Circulation. Journal of Vascular Surgery. 65(6). 1863–1863. 1 indexed citations
19.
Ott, Christian, Peter Linz, Agnes Jumar, et al.. (2017). SGLT-2-Inhibition with dapagliflozin reduces tissue sodium content. Diabetologie und Stoffwechsel. 12(S 01). S1–S84. 2 indexed citations
20.
Ott, Christian, Markus P. Schneider, Ulrike Raff, et al.. (2012). Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension. British Journal of Clinical Pharmacology. 75(1). 129–135. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnes Bosch Breakdown of academic impact, for papers by Marina V. Karg Breakdown of academic impact, for papers by Susanne Jung Breakdown of academic impact, for papers by Giuseppe Andronico Breakdown of academic impact, for papers by Anna L. Emanuel Breakdown of academic impact, for papers by Tetsutaro Matayoshi Breakdown of academic impact, for papers by Graham S. Scott Breakdown of academic impact, for papers by Philip A. Coates Breakdown of academic impact, for papers by Eita Kumagai Breakdown of academic impact, for papers by L Hanna
Rankless by CCL
2026